Skip to main content
Advertisement
Advertisement

LLY

LLY logo

Eli Lilly & Co.

1,183.46
USD
Sponsored
+1.57
+0.13%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

1,183.81

+0.35
+0.03%

LLY Earnings Reports

Positive Surprise Ratio

LLY beat 30 of 42 last estimates.

71%

Next Report

Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.56B
/
$10.00
Implied change from Q2 26 (Revenue/ EPS)
-1.80%
/
+19.33%
Implied change from Q3 25 (Revenue/ EPS)
+28.18%
/
+42.45%

Eli Lilly & Co. earnings per share and revenue

On Aug 05, 2026, LLY reported earnings of 8.38 USD per share (EPS) for Q2 26, beating the estimate of 6.06 USD, resulting in a 38.14% surprise. Revenue reached 22.97 billion, compared to an expected 20.93 billion, with a 9.75% difference. The market reacted with a +4.86% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 10.00 USD, with revenue projected to reach 22.56 billion USD, implying an increase of 19.33% EPS, and decrease of -1.80% in Revenue from the last quarter.
FAQ
For Q2 2026, Eli Lilly & Co. reported EPS of $8.38, beating estimates by 38.14%, and revenue of $22.97B, 9.75% above expectations.
The stock price moved up 4.86%, changed from $1.12K before the earnings release to $1.17K the day after.
The next earning report is scheduled for Oct 29, 2026.
Based on 10 analysts, Eli Lilly & Co. is expected to report EPS of $10.00 and revenue of $22.56B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement